People
Professor Mark Rutherford
Professor of Biostatistics
School/Department: Population Health Sciences, Department of
Telephone: +44 (0)116 229 7292
Email: mjr40@leicester.ac.uk
Profile
I’m a Professor of Biostatistics at the University of Leicester and also hold a visiting scientist position at the Section of Cancer Surveillance International Agency for Research on Cancer. My main areas of interest are in methods for the analysis of population-based registry data.
I have been involved in a number of methodological and applied papers for comparisons of cancer survival metrics; with a focus on developing measures that are intuitive but that retain appropriate fairness when comparing across population groups (e.g. across socioeconomic groups or across countries). A researcher in our group (Sarwar Mozumder) has developed a web-based tool for understanding Cancer Survival measures: https://interpret.le.ac.uk/.
I am also involved in applying and adapting the methods used in cancer epidemiology to other disease areas. I have been involved in developing an approach for providing up-to-date estimates of risk from prognostic models and developing methods for validating prognostic models developed in competing risks settings. I also collaborate on projects in an RCT and meta-analysis setting; where interest may be in competing risks, multistate modelling or extrapolation of survival functions.
Research
Publications
Some selected recent papers are given below:
Stannard R, Lambert PC, Andersson TM, Khan S, Lyratzopoulos G, Syriopoulou E, Rutherford MJ. Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in England. BMJ Oncology. 2026;5:e000999. https://doi.org/10.1136/bmjonc-2025-000999
Paul C. Lambert, Therese M.L. Andersson, Tor Åge Myklebust, Bjørn Møller, Mark J. Rutherford; Monitoring Temporal Trends in Cancer Survival: Choosing Appropriate Standards When Accounting for Age and Other-Cause Mortality Variation Over Time. Cancer Epidemiol Biomarkers Prev 1 July 2025; 34 (7): 1141–1148. https://doi.org/10.1158/1055-9965.EPI-24-1727
Latimer, N.R., Rutherford, M.J. Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know. PharmacoEconomics42, 1073–1090 (2024). https://doi.org/10.1007/s40273-024-01406-7
My full Google Scholar profile is available here: https://scholar.google.com/citations?user=SAx4X_0AAAAJ&hl=en